| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 05/03/2001 | WO2001030802A2 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 05/02/2001 | CN1293198A Process for preparing rare-sinsenoside |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 03/14/2001 | EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/13/2001 | US6200965 Use of same to reduce plasma levels of testosterone and/or dyhydrotestosterone to treat prostate cancer and benign prostatic hypertrophy |
| 03/08/2001 | WO2001015717A1 Brain cell or nerve cell protecting agents comprising ginseng |
| 03/06/2001 | US6197761 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives |
| 02/28/2001 | CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 02/07/2001 | EP1074558A1 Process for the preparation of mometasone furoate |
| 02/07/2001 | CN1282744A Preparation of furoic acid momisone |
| 02/06/2001 | CA2172144C Hapten-marked peptides |
| 01/30/2001 | US6180781 Process for making mometasone furoate monohydrate |
| 01/24/2001 | EP1070725A1 Solid dispersion containing sialic acid derivative |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/23/2001 | US6177560 Direct esterification of the 17 hydroxyl group without prior protection of the free 11 hydroxy function. |
| 01/23/2001 | US6177418 Epoxidized and/or hydroxylated prostane derivatives derived from a fusidium coccineum fungus metabolite isolated from metabolite mixture of fusidic acid |
| 01/18/2001 | WO2000047215A3 Methods for anti-tumor therapy |
| 01/16/2001 | US6175035 Method of producing betulinic acid |
| 01/11/2001 | WO2001002020A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 01/09/2001 | US6172052 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 01/04/2001 | WO2001000653A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/04/2001 | CA2377492A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 11/29/2000 | CN1058971C Prodn. technology for extracting fine sasanquasaponin by super filtration film method |
| 11/21/2000 | US6150336 Steroidal glycosides |
| 11/14/2000 | CA2271965A1 Method of producing betulinic acid |
| 11/09/2000 | WO2000066612A1 Androgen glycosides and androgenic activity thereof |
| 11/09/2000 | WO2000066611A1 Steroid derivatives |
| 11/09/2000 | CA2372493A1 Steroid derivatives |
| 11/07/2000 | US6143736 Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 10/31/2000 | CA2152621C Pharmaceutical compositions comprising contignasterol compounds |
| 10/03/2000 | US6127353 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| 09/28/2000 | WO2000056757A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 09/28/2000 | CA2365081A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 09/27/2000 | EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor |
| 09/06/2000 | CN1056152C 唾液酸衍生物 Sialic acid derivatives |
| 09/06/2000 | CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds |
| 08/30/2000 | CN1055922C Lactone compound and process of prodn. thereof |
| 08/29/2000 | US6110906 Androgen derivatives for use in the inhibition of sex steroid activity |
| 08/24/2000 | WO2000048608A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb¿1? |
| 08/23/2000 | EP1028734A1 $i(SPECIFIC) STEADY-STATE R-TYPE Ca?2+ CHANNEL BLOCKERS AND USE THEREOF |
| 08/23/2000 | EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 08/22/2000 | US6107036 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 08/17/2000 | WO2000047215A2 Methods for anti-tumor therapy |
| 08/02/2000 | EP1024146A1 The use of steroid saponin compounds to prevent senility, and novel steroid saponin compounds |
| 08/02/2000 | EP1023315A1 Methods and compositions for destruction of selected proteins |
| 08/02/2000 | EP0721956B1 21-substituted steroid compound |
| 07/25/2000 | US6093805 Glycoside compounds and methods of synthesis |
| 07/06/2000 | WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/05/2000 | EP0876392B1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 07/05/2000 | CN1259137A Estra-5(10), 7-dienes with estrogenic activity |
| 06/29/2000 | WO2000037481A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb¿1? |
| 06/29/2000 | DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases |
| 06/15/2000 | WO2000034306A1 17β-ACYL-17α-PROPYNYL-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES |
| 06/13/2000 | US6075132 Ursodeoxycholic acid derivatives and methods for producing them |
| 06/13/2000 | CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates |
| 06/08/2000 | WO2000032197A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 06/06/2000 | CA2114830C Lactone compound and process of production thereof |
| 05/31/2000 | EP0721459B1 Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry |
| 05/24/2000 | CN1254344A Estrogenic 10-Noradnrost-17-one derivatives with aromatic B-ring |
| 05/10/2000 | EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life |
| 05/10/2000 | CN1052237C Steroids with 17-spiromethylene lactone or ortho -hydroxyl inner ether base |
| 05/09/2000 | US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer |
| 05/03/2000 | CN1252000A Pharmaceutical compositions having appetite suppressant activity |
| 04/26/2000 | CN1251369A Method for preparing quasi-ginsenoside P11 |
| 04/25/2000 | CA2001936C Methods and compositions for controlling ocular hypertension with angiostatic steroids |
| 04/20/2000 | WO2000021977A1 Pregnane glucuronides |
| 04/20/2000 | CA2346693A1 Pregnane glucuronides |
| 04/12/2000 | CN1051316C Cortinoid derivative, its producing process and medicine containing the same |
| 04/11/2000 | CA2182086C Use of mometasone furoate for treating airway passage and lung diseases |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 03/15/2000 | EP0496854B1 Method for preparation of 20-METHYL-5,7-PREGNADIENE-3$g(b),21-DIOL DERIVATIVES |
| 03/15/2000 | CN1050365C Method for prepn. of hexan-2-olefin pyranoseoside of alcohol and phenol |
| 03/02/2000 | WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent |
| 03/02/2000 | WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/02/2000 | CN1243128A Semisynthesizing method for 20(S)-ginsenoside Rg3, and use in medicine |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/26/2000 | EP0973534A1 Pharmaceutical compositions having appetite suppressant activity |
| 01/26/2000 | CN1242374A Process for extracting ginsenoside Re, and use of medicine thereof |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/18/2000 | US6015806 Topical use in the treatment of androgen-dependent diseases associated with the skin. |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 12/22/1999 | EP0515386B1 Glycoalkaloids |
| 12/22/1999 | CN1047598C Dammarane-type saponin ginseng lowhydric alcohol derivative and prepn. method |
| 12/09/1999 | WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES |
| 11/30/1999 | US5994335 17-azolyl steroids useful as androgen synthesis inhibitors |
| 11/24/1999 | CN1046736C 'Delta' 16 unsaturated and (1) heterocyclic steroids useful s steroid (1)-20 lyase inhibitors |
| 11/03/1999 | EP0362279B2 Saponin adjuvant |
| 11/02/1999 | US5977094 Methods and compositions using Δ16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors |
| 10/21/1999 | WO1999052931A1 Solid dispersion containing sialic acid derivative |
| 10/12/1999 | US5965548 For treatment of prostatic cancer, breast cancer |
| 10/06/1999 | EP0597018B1 Glycosidation reaction |
| 09/28/1999 | US5958770 Glycoalkaloids |
| 09/23/1999 | WO1999047542A1 Drugs containing as the main ingredient 21-substituted glycosyl steroid compounds |
| 09/07/1999 | US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch |
| 08/31/1999 | US5945404 21-Substituted steroid compound |
| 08/17/1999 | US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 08/11/1999 | EP0649431B1 17-amino substituted 4-azasteroid 5-alpha-reductase inhibitors |